A Randomized Controlled Trial Evaluating Sildenafil Citrate in Relieving Ureteral Stent Related Symptoms
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
Despite its beneficial effect, ureteral stents may produce symptoms (such as hematuria,
dysuria, frequency, urgency, urge incontinence and suprapubic or flank pain) that affect the
quality of life in 70-80%.
This study will be conducted to evaluate the role of Phosphodiestrase 5 inhibitor (Sildenafil
Citrate) in relieving these symptoms.